Andere talen Adicet Bio, Inc.

Aandelen

ACET

US0070021086

Geschatte realtime Cboe BZX Andere beurzen 18:19:00 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,675 ^USD	-3,18%		+10,86%	-10,85%

22/04	Adicet Bio, Inc. benadrukt preklinische gegevens die de IND-gereedheid voor ADI-270 ondersteunen in een mondelinge presentatie op de 27e jaarlijkse ASGCT-bijeenkomst	CI
19/03	Adicet Bio, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference	07/05
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	30/04
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy 27th Annual Meeting	23/04
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	22/04
Adicet Bio, Inc. Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the ASGCT 27th Annual Meeting	22/04
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference	08/04
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	28/03
North American Morning Briefing : Markets Steady -2-	26/03
Adicet Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Adicet Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	19/03
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress	19/03
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	11/03
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	01/03
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	05/02
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	31/01
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares	26/01
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares	25/01
Sector Update: Health Care Stocks Mixed Premarket Tuesday	23/01
Adicet Bio Prices $85.2 Million Share Offering	23/01
Adicet Bio, Inc. Announces Pricing of Public Offering	23/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Adicet Bio, Inc.

Aandelen

ACET

US0070021086

Andere talen

Filters